Parallel Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.52K Buy
464
+142
+44% +$1.45K ﹤0.01% 2997
2025
Q4
$3.21K Sell
322
-296
-48% -$2.83K ﹤0.01% 2994
2025
Q3
$5.53K Buy
618
+296
+92% +$2.74K ﹤0.01% 2739
2025
Q2
$3.04K Buy
+322
New +$2.84K ﹤0.01% 2918
2025
Q1
Sell
-63
Closed -$600 3509
2024
Q4
$600 Buy
63
+9
+17% +$91 ﹤0.01% 3193
2024
Q3
$606 Buy
+54
New +$574 ﹤0.01% 3151
2024
Q1
Sell
-28
Closed -$204 3295
2023
Q4
$204 Buy
+28
New +$221 ﹤0.01% 3165
2022
Q4
Sell
-6
Closed 3348
2022
Q3
$0 Buy
+6
New +$123 ﹤0.01% 3114
2021
Q4
Sell
-184
Closed -$4K 3052
2021
Q3
$4K Buy
+184
New +$4.45K ﹤0.01% 2424

Other funds holding AHCO

Parallel Advisors's AHCO Position: Q1 2026 in Review

Parallel Advisors increased its AdaptHealth (AHCO) stake by 44% in Q1 2026, buying an estimated $1.45K and bringing the position to 464 shares worth $5.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2997.

Parallel Advisors first reported a position in AHCO in Q3 2021 and has held it in 9 quarters since. The position peaked at $5.53K in Q3 2025. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Parallel Advisors held 464 shares of AdaptHealth worth $5.52K as of Q1 2026.
  • Parallel Advisors bought 142 AdaptHealth shares in Q1 2026, an estimated $1.45K.
  • AdaptHealth made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2997 holding.
  • Parallel Advisors first reported a position in AdaptHealth in Q3 2021 and has held it in 9 quarters since.
  • Parallel Advisors's AdaptHealth position peaked at $5.53K in Q3 2025.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.